These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 28389117)

  • 1. Early stage hepatocellular carcinoma in the elderly: A SEER database analysis.
    Oweira H; Petrausch U; Helbling D; Schmidt J; Mannhart M; Mehrabi A; Schöb O; Giryes A; Abdel-Rahman O
    J Geriatr Oncol; 2017 Jul; 8(4):277-283. PubMed ID: 28389117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of liver-directed local tumor therapy in the management of hepatocellular carcinoma with extrahepatic metastases: a SEER database analysis.
    Abdel-Rahman O
    Expert Rev Gastroenterol Hepatol; 2017 Feb; 11(2):183-189. PubMed ID: 27830958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant radiotherapy provided survival benefit compared to adjuvant radiotherapy for hepatocellular carcinoma.
    Lin H; Li X; Liu Y; Hu Y
    ANZ J Surg; 2018 Oct; 88(10):E718-E724. PubMed ID: 29399938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incorporation of alpha-fetoprotein(AFP) into subclassification of BCLC C stage hepatocellular carcinoma according to a 5-year survival analysis based on the SEER database.
    Zhang N; Gu J; Yin L; Wu J; Du MY; Ding K; Huang T; He X
    Oncotarget; 2016 Dec; 7(49):81389-81401. PubMed ID: 27835609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of long-term survival of patients with solitary large hepatocellular carcinoma of BCLC stage A after liver resection or transarterial chemoembolization: a propensity score analysis.
    Zhu SL; Ke Y; Peng YC; Ma L; Li H; Li LQ; Zhong JH
    PLoS One; 2014; 9(12):e115834. PubMed ID: 25541684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of site-specific extra-hepatic disease in hepatocellular carcinoma: a SEER database analysis.
    Oweira H; Petrausch U; Helbling D; Schmidt J; Mehrabi A; Schöb O; Giryes A; Abdel-Rahman O
    Expert Rev Gastroenterol Hepatol; 2017 Jul; 11(7):695-701. PubMed ID: 28276812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical evaluation of the American Joint Commission on Cancer (AJCC) 8th edition staging system for patients with Hepatocellular Carcinoma (HCC): A Surveillance, Epidemiology, End Results (SEER) analysis.
    Kamarajah SK; Frankel TL; Sonnenday C; Cho CS; Nathan H
    J Surg Oncol; 2018 Mar; 117(4):644-650. PubMed ID: 29127719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Birth cohort-specific disparities in hepatocellular carcinoma stage at diagnosis, treatment, and long-term survival.
    Yan M; Ha J; Aguilar M; Bhuket T; Liu B; Gish RG; Cheung R; Wong RJ
    J Hepatol; 2016 Feb; 64(2):326-332. PubMed ID: 26386160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aggressive therapeutic strategies improve the survival of hepatocellular carcinoma patients with performance status 1 or 2: a propensity score analysis.
    Hsu CY; Liu PH; Lee YH; Hsia CY; Huang YH; Chiou YY; Tsai YJ; Nagaria TS; Huo TI
    Ann Surg Oncol; 2015 Apr; 22(4):1324-31. PubMed ID: 25326394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Squamous Cell Carcinoma of the Bladder: A SEER Database Analysis.
    Abdel-Rahman O
    Clin Genitourin Cancer; 2017 Jun; 15(3):e463-e468. PubMed ID: 27876505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in Survival Between First-Line Radiofrequency Ablation versus Surgery for Early-Stage Hepatocellular Carcinoma: A Population Study Using the Surveillance, Epidemiology, and End Results Database.
    Lin Y; Pan XB
    Med Sci Monit; 2020 May; 26():e921782. PubMed ID: 32461542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival improvement and prognosis for hepatocellular carcinoma: analysis of the SEER database.
    Ding J; Wen Z
    BMC Cancer; 2021 Oct; 21(1):1157. PubMed ID: 34715816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and cost of radiofrequency ablation and stereotactic body radiotherapy for treatment of early-stage hepatocellular carcinoma: An analysis of SEER-medicare.
    Parikh ND; Marshall VD; Green M; Lawrence TS; Razumilava N; Owen D; Singal AG; Feng M
    J Med Imaging Radiat Oncol; 2018 Oct; 62(5):673-681. PubMed ID: 29877615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management and outcomes among patients with sarcomatoid hepatocellular carcinoma: A population-based analysis.
    Wu L; Tsilimigras DI; Farooq A; Hyer JM; Merath K; Paredes AZ; Mehta R; Sahara K; Shen F; Pawlik TM
    Cancer; 2019 Nov; 125(21):3767-3775. PubMed ID: 31299092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection of treatment modalities for hepatocellular carcinoma at stages T1 and T2: A preliminary analysis based on the Surveillance, Epidemiology, and End Results registry database.
    Han B; Yao H; Shao L; Guo X; Han L; Gomes Romeiro F; Mancuso A; Qi X
    J BUON; 2018; 23(3):611-621. PubMed ID: 30003727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of transarterial chemoembolization with radiofrequency ablation for unresectable Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma: a propensity score matching.
    Chen RX; Gan YH; Ge NL; Chen Y; Ma H; Wang Y; Zhang BH; Wang YH; Ye SL; Luo JF; Ren ZG
    J Gastroenterol Hepatol; 2016 Feb; 31(2):442-9. PubMed ID: 26259976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermal Ablation versus Surgical Resection for the Treatment of Stage T1 Hepatocellular Carcinoma in the Surveillance, Epidemiology, and End Results Database Population.
    Mironov O; Jaberi A; Kachura JR
    J Vasc Interv Radiol; 2017 Mar; 28(3):325-333. PubMed ID: 28073607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma.
    Mathur AK; Osborne NH; Lynch RJ; Ghaferi AA; Dimick JB; Sonnenday CJ
    Arch Surg; 2010 Dec; 145(12):1158-63. PubMed ID: 21173289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant transarterial chemoembolization after curative resection of hepatocellular carcinoma: propensity score analysis.
    Jiang JH; Guo Z; Lu HF; Wang XB; Yang HJ; Yang FQ; Bao SY; Zhong JH; Li LQ; Yang RR; Xiang BD
    World J Gastroenterol; 2015 Apr; 21(15):4627-34. PubMed ID: 25914472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiofrequency Ablation
    Xu J; Noda C; Erickson A; Mokkarala M; Charalel R; Ramaswamy R; Tao YU; Akinwande O
    Anticancer Res; 2018 Nov; 38(11):6381-6386. PubMed ID: 30396961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.